5068202025-01-012025-03-315068202025-03-315068202025-01-012025-03-31CompositionOfBoardOfDirectors15068202025-03-31CompositionOfBoardOfDirectors15068202025-01-012025-03-31CompositionOfBoardOfDirectors25068202025-03-31CompositionOfBoardOfDirectors25068202025-01-012025-03-31CompositionOfBoardOfDirectors35068202025-03-31CompositionOfBoardOfDirectors35068202025-01-012025-03-31CompositionOfBoardOfDirectors45068202025-03-31CompositionOfBoardOfDirectors45068202025-01-012025-03-31CompositionOfBoardOfDirectors55068202025-03-31CompositionOfBoardOfDirectors55068202025-01-012025-03-31CompositionOfBoardOfDirectors65068202025-03-31CompositionOfBoardOfDirectors65068202025-01-012025-03-31CompositionOfBoardOfDirectors75068202025-03-31CompositionOfBoardOfDirectors75068202025-01-012025-03-31CompositionOfBoardOfDirectors85068202025-03-31CompositionOfBoardOfDirectors85068202025-01-012025-03-31CompositionOfCommittees145068202025-03-31CompositionOfCommittees145068202025-01-012025-03-31CompositionOfCommittees155068202025-03-31CompositionOfCommittees155068202025-01-012025-03-31CompositionOfCommittees165068202025-03-31CompositionOfCommittees165068202025-01-012025-03-31CompositionOfCommittees415068202025-03-31CompositionOfCommittees415068202025-01-012025-03-31CompositionOfCommittees425068202025-03-31CompositionOfCommittees425068202025-01-012025-03-31CompositionOfCommittees435068202025-03-31CompositionOfCommittees435068202025-01-012025-03-31CompositionOfCommittees685068202025-03-31CompositionOfCommittees685068202025-01-012025-03-31CompositionOfCommittees695068202025-03-31CompositionOfCommittees695068202025-01-012025-03-31CompositionOfCommittees705068202025-03-31CompositionOfCommittees705068202025-01-012025-03-31CompositionOfCommittees715068202025-03-31CompositionOfCommittees715068202025-01-012025-03-31CompositionOfCommittees955068202025-03-31CompositionOfCommittees955068202025-01-012025-03-31CompositionOfCommittees965068202025-03-31CompositionOfCommittees965068202025-01-012025-03-31CompositionOfCommittees975068202025-03-31CompositionOfCommittees975068202025-01-012025-03-31CompositionOfCommittees985068202025-03-31CompositionOfCommittees985068202025-01-012025-03-31CompositionOfCommittees995068202025-03-31CompositionOfCommittees995068202025-01-012025-03-31CompositionOfCommittees1225068202025-03-31CompositionOfCommittees1225068202025-01-012025-03-31CompositionOfCommittees1235068202025-03-31CompositionOfCommittees1235068202025-01-012025-03-31CompositionOfCommittees1245068202025-03-31CompositionOfCommittees1245068202025-03-31MeetingOfBoardOfDirectors15068202025-01-012025-03-31MeetingOfBoardOfDirectors15068202025-03-31MeetingOfBoardOfDirectors25068202025-01-012025-03-31MeetingOfBoardOfDirectors25068202025-03-31MeetingOfBoardOfDirectors35068202025-01-012025-03-31MeetingOfBoardOfDirectors35068202025-03-31MeetingOfBoardOfDirectors45068202025-01-012025-03-31MeetingOfBoardOfDirectors45068202025-03-31MeetingOfBoardOfDirectors55068202025-01-012025-03-31MeetingOfBoardOfDirectors55068202025-03-31MeetingOfBoardOfDirectors65068202025-01-012025-03-31MeetingOfBoardOfDirectors65068202025-01-012025-03-31MeetingOfCommittees15068202025-03-31MeetingOfCommittees15068202025-01-012025-03-31MeetingOfCommittees25068202025-03-31MeetingOfCommittees25068202025-01-012025-03-31MeetingOfCommittees35068202025-03-31MeetingOfCommittees35068202025-01-012025-03-31MeetingOfCommittees45068202025-03-31MeetingOfCommittees45068202025-01-012025-03-31MeetingOfCommittees55068202025-03-31MeetingOfCommittees55068202025-01-012025-03-31MeetingOfCommittees65068202025-03-31MeetingOfCommittees65068202025-01-012025-03-31MeetingOfCommittees75068202025-03-31MeetingOfCommittees75068202025-01-012025-03-31CyberSecurityIncidenceOrBreachesOrLossOfDataEvent15068202024-12-315068202025-03-31OngoingTaxLitigationsOrDisputesDomain15068202025-03-31OngoingTaxLitigationsOrDisputesDomain25068202025-03-31OngoingTaxLitigationsOrDisputesDomain3xbrli:pure506820ASTRAZENNOTLISTEDINE203A01020ASTRAZENECA PHARMA INDIA LIMITED2024-04-012025-03-31Yearly2025-03-31EquitytruetruefalseDisclosure related to acquisition of shares or voting rights in unlisted companies is not applicable to the Company.falseDisclosure related to imposition of fine or penalty is not applicable to the Company.truefalseThe Company has not provided loans, granted guarantees, comfort letters, securities.trueTop 500 listed entitiestrueA00366OriginaltruefalseMsSHILPA DIVEKAR NIRULA06619353Non-Executive - Independent DirectorChairperson1973-11-30falseActiveNA2021-12-292021-12-2939.032220MsREVATHY ASHOKACLPR3951Q00057539Non-Executive - Independent DirectorNot Applicable1959-01-16falseActiveNA2016-12-022021-12-0299.2955103MsMONICA WIDHANI07674403Non-Executive - Independent DirectorNot Applicable1959-01-18falseActiveNA2024-09-252024-09-256.055583MrSANJEEV KUMAR PANCHALAHUPP0659F09823879Executive DirectorNot Applicable1977-08-11falseActiveNA2023-01-011010MrJESUS JAVIER DIAZ-ROPERO ESTESO10835384Non-Executive - Non Independent DirectorNot Applicable1972-02-05falseActiveNA2024-11-131000Foreign National, Hence PAN is not available.MsSYLVIA LORENA VARELA RAMONZZZZZ9999Z10410837Non-Executive - Non Independent DirectorNot Applicable1966-03-20falseActiveNA2023-12-211011Foreign National, Hence PAN is not available.MsHOOI BIEN CHUAH10381891Non-Executive - Non Independent DirectorNot Applicable1975-01-17falseActiveNA2023-11-091010Foreign National, Hence PAN is not available.MsBHAVANA AGRAWALAFMPA5396L10485441Executive DirectorNot Applicable1978-11-04falseActiveNA2024-02-081010truetruetruetruetrueAudit Committee07674403MONICA WIDHANINon-Executive - Independent DirectorChairperson2024-09-25Audit Committee06619353SHILPA DIVEKAR NIRULANon-Executive - Independent DirectorMember2022-02-08Audit Committee10381891HOOI BIEN CHUAHNon-Executive - Non Independent DirectorMember2024-02-08Nomination and remuneration committee00057539REVATHY ASHOKNon-Executive - Independent DirectorChairperson2022-02-08Nomination and remuneration committee06619353SHILPA DIVEKAR NIRULANon-Executive - Independent DirectorMember2024-09-25Nomination and remuneration committee10410837SYLVIA LORENA VARELA RAMONNon-Executive - Non Independent DirectorMember2024-05-28Stakeholders Relationship Committee10410837SYLVIA LORENA VARELA RAMONNon-Executive - Non Independent DirectorChairperson2024-02-08Stakeholders Relationship Committee00057539REVATHY ASHOKNon-Executive - Independent DirectorMember2017-02-02Stakeholders Relationship Committee09823879SANJEEV KUMAR PANCHALExecutive DirectorMember2023-01-01Stakeholders Relationship Committee10485441BHAVANA AGRAWALExecutive DirectorMember2024-02-08Risk Management Committee07674403MONICA WIDHANINon-Executive - Independent DirectorChairperson2024-09-25Risk Management Committee09823879SANJEEV KUMAR PANCHALExecutive DirectorMember2023-01-01Risk Management Committee10485441BHAVANA AGRAWALExecutive DirectorMember2024-02-08Risk Management Committee99999999SRIKANTH B SSite Lead - India OperationsMember2024-08-08Mr. Srikanth B.S. is not a Director, hence DIN is not available.Risk Management Committee99999999AMARPREET KAUR AHUJACountry HR DirectorMember2020-08-03Ms. Amarpreet Kaur Ahuja is not a Director, hence DIN is not available.Corporate Social Responsibility Committee10381891HOOI BIEN CHUAHNon-Executive - Non Independent DirectorChairperson2024-02-08Corporate Social Responsibility Committee00057539REVATHY ASHOKNon-Executive - Independent DirectorMember2017-02-02Corporate Social Responsibility Committee09823879SANJEEV KUMAR PANCHALExecutive DirectorMember2023-01-012024-11-13true8722024-12-1834true8522025-02-1154true8732025-03-0420true8732025-03-04true8522025-03-2621true873Audit Committee2024-11-13true4320Audit Committee2025-02-1189true3220Nomination and remuneration committee2024-11-13true3320Nomination and remuneration committee2025-03-04110true3220Nomination and remuneration committee2025-03-04true3220Stakeholders Relationship Committee2024-11-13true4410Risk Management Committee2025-02-11true5312truetruetruetrueYestruetruetrueManasa. RCompany Secretary and Compliance OfficerYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaNAYeswww.astrazeneca.com/indiaNAYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaNAYeswww.astrazeneca.com/indiaNANAYeswww.astrazeneca.com/indiaNANAYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaNAYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaNAYeswww.astrazeneca.com/indiaYeswww.astrazeneca.com/indiaYesYesYesYesYesYesYesNAYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNANANANAYesNAYesYesYesYesYesYesYesYesNANAManasa. RCompany Secretary and Compliance OfficerNAManasa. RCompany Secretary and Compliance Officertrue12024-12-221. The Company's Twitter account was unexpectedly locked or hacked, and are unable to retrieve it. The Company have informed the AstraZeneca Global Cyber Security team and have contacted Twitter Support requesting for the account to be unlocked/ recovered. 2. An FIR has also been filed with the Cyber Crime Unit, Bangalore. 3. Currently no malicious content have been posted from our Twitter handle.Manasa. RCompany Secretary and Compliance OfficerBangalore2025-04-2900000The office of Deputy Commissioner of Income Tax, TP 1(1)(1), Bangalore2025-04-15Company has received an order from the Transfer Pricing Officer being issued under section 92 CA (3) of the Income Tax Act, 1961 for assessment year 2022-23, wherein adjustment on the legacy issues has been proposed.The matter will be challenged before appropriate appellate forum, once the draft order is received. The expected overall financial implication cannot be determined at this stage. It will be determined only upon passing of the final assessment order for the assessment year 2022-23. However, quantum of claim as per the captioned order is Rs. 11.96 crores (approx.) excluding interest and penalty.Assessment Unit, Income Tax Department2025-04-15Company has received a draft order from the Assessment Unit being passed under section 144C(1) read with section 143(3) of the Income Tax Act, 1961 for assessment year 2022-23, wherein adjustment on the legacy transfer pricing issues have been proposed.The matter will be challenged before the Dispute Resolution Panel by filing an appeal. The expected overall financial implication cannot be determined at this stage. It will be determined only upon passing of the final assessment order for the assessment year 2022- 23. However, quantum of claim as per the captioned order is Rs. 11.96 crores (approx.) excluding interest and penalty.Assistant Commissioner of Income tax2018-11-28Company has received a draft Order Giving Effect to the order of Hon’ble Income-tax Appellate Tribunal, being passed under section 144C(1) read with section 143(3) of the Income Tax Act, 1961 for assessment year 2014-15, wherein major adjustments done on the transfer pricing as well as corporate tax issues have been deleted.The present order is a draft Order Giving Effect to the order of Hon’ble Income-tax Appellate Tribunal. The quantum of tax relief as per the captioned order is Rs. 35.22 crores (approx.) excluding interest.